NASDAQ:MIRA

MIRA Pharmaceuticals (MIRA) Stock Price, News & Analysis

MIRA Pharmaceuticals logo
$0.37 -0.22 (-37.68%)
Closing price 11/19/2026 04:00 PM Eastern
Extended Trading
$0.38 +0.01 (+2.63%)
As of 08:38 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About MIRA Pharmaceuticals Stock (NASDAQ:MIRA)

Advanced

Key Stats

Today's Range
$0.33
▼
$0.59
50-Day Range
$0.37
▼
$0.91
52-Week Range
$0.33
▼
$1.69
Volume
589,632 shs
Average Volume
158,924 shs
Market Capitalization
$15.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.50
Consensus Rating
Hold

Company Overview

MIRA Pharmaceuticals is a clinical-stage pharmaceutical company developing oral drug candidates for neurological and neuropsychiatric conditions. Its pipeline includes MIRA1a, an investigational synthetic cannabinoid analog being studied for potential use in conditions such as anxiety and chronic pain.

The company has also added Ketamir-2, an investigational oral ketamine analog being developed for potential treatment of depression and neuropathic pain. These candidates remain in development and are not approved medicines.

AI Generated. May Contain Errors.

MIRA Pharmaceuticals Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
55th Percentile Overall Score

MIRA MarketRank™: 
2.76151202749 of 5 stars

MIRA Pharmaceuticals scored higher than 55% of companies evaluated by MarketBeat, and ranked 338th out of 845 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    MIRA Pharmaceuticals has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on no strong buy ratings, 2 buy ratings, no hold ratings, and 1 sell rating.

  • Upside Potential

    MIRA Pharmaceuticals has a consensus price target of $3.50, representing about 850.3% upside from its current price of $0.37.

  • Amount of Analyst Coverage

    MIRA Pharmaceuticals has only been the subject of 2 research reports in the past 90 days.

  • Read more about MIRA Pharmaceuticals' stock forecast and price target.
  • Percentage of Shares Shorted

    0.84% of the float of MIRA Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    MIRA Pharmaceuticals has a short interest ratio ("days to cover") of 1.44, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in MIRA Pharmaceuticals has recently decreased by 19.27%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    MIRA Pharmaceuticals does not currently pay a dividend.

  • Dividend Growth

    MIRA Pharmaceuticals does not have a long track record of dividend growth.

  • News Sentiment

    MIRA Pharmaceuticals has a news sentiment score of 0.45. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for MIRA Pharmaceuticals this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, MIRA Pharmaceuticals insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    19.89% of the stock of MIRA Pharmaceuticals is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    35.16% of the stock of MIRA Pharmaceuticals is held by institutions.

  • Read more about MIRA Pharmaceuticals' insider trading history.
Receive MIRA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MIRA Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MIRA Stock News Headlines

Beyond NVDA: The World’s Next #1 Company?
This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvidia's. A NASA scientist says the technology behind it is bigger than AI. Musk calls it "Amazing," and a Nobel Prize winner describes its power as "unprecedented in the history of life on Earth." Adam O'Dell, Chief Investment Strategist at Money and Markets, names the company at the center of it all.tc pixel
MIRA Pharmaceuticals (NASDAQ:MIRA) Shares Up 0.3% - Time to Buy?
See More Headlines

MIRA Stock Analysis - Frequently Asked Questions

MIRA Pharmaceuticals' stock was trading at $1.51 at the beginning of 2026. Since then, MIRA stock has decreased by 75.6% and is now trading at $0.3683.

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) announced its quarterly earnings data on Monday, November, 16th. The company reported ($0.03) EPS for the quarter, hitting analysts' consensus estimates of ($0.03).

MIRA Pharmaceuticals (MIRA) raised $9 million in an initial public offering on Wednesday, August 2nd 2023. The company issued 1,275,000 shares at $6.00-$8.00 per share.

Top institutional investors of MIRA Pharmaceuticals include State Street Corp (0.18%). Insiders that own company stock include Erez Aminov and Brian Patrick Mcnulty.
View institutional ownership trends
.

Shares of MIRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MIRA Pharmaceuticals investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), AST SpaceMobile (ASTS), ImmunityBio (IBRX), Palantir Technologies (PLTR), D-Wave Quantum (QBTS) and SoundHound AI (SOUN).

Company Calendar

Last Earnings
11/16/2026
Today
11/20/2026
Next Earnings (Estimated)
12/02/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:MIRA
Previous Symbol
NASDAQ:MIRA
CIK
1904286
Fax
N/A
Employees
2
Year Founded
1978

Price Target and Rating

High Price Target
$3.50
Low Price Target
$3.50
Potential Upside/Downside
+850.3%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.24)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$10.44 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-112.41%
Return on Assets
-108.40%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
16.98
Quick Ratio
200.08

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.16 per share
Price / Book
2.30

Miscellaneous

Outstanding Shares
42,020,000
Free Float
33,664,000
Market Cap
$15.48 million
Optionable
Not Optionable
Beta
1.65

Social Links

Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:MIRA) was last updated on 11/19/2026 by MarketBeat.com Staff.
From Our Partners